Legionella Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Legionella Testing Market
The global legionella testing market size was valued at USD 317.3 million in 2023 and is projected to grow from USD 346.8 million in 2024 to USD 726.3 million by 2032, exhibiting a CAGR of 9.7% during the forecast period.
The pandemic has had a full-size impact on the Legionella checking-out marketplace. With elevated cognizance of indoor air first-rate and fitness dangers, the call for Legionella testing offerings has surged. Organizations, particularly in the healthcare and hospitality sectors, prioritize Legionella checking out to ensure the protection of their premises. Additionally, stringent policies and guidelines for Legionella management and prevention have driven legionella testing market growth.
The Legionella testing marketplace is commonly pushed via growing awareness of Legionnaires' disorder and the significance of water protection. Stringent policies and hints for Legionella manipulation in diverse industries, mainly healthcare and hospitality, use demand to check out offerings.
The combat against Legionnaires' disease is improving. Sustainability is becoming a pinnacle of precedence inside the Legionella checking-out marketplace. Manufacturers are innovating with green checking out kits and processes. These advancements aim to limit reliance on harsh chemical substances that may pose fitness and environmental risks. This greener method no longer safeguards human health from Legionella microorganisms; however, it also reduces the ecological footprint of the checking-out method, leading to the expansion of the legionella testing market share. By embracing eco-friendly solutions, the Legionella trying out industry is putting a critical balance between public fitness safety and environmental duty.
Comprehensive Analysis of Legionella Testing Market
The Legionella trying-out market is witnessing a significant boom, pushed by the rising prevalence of Legionnaire's sickness and the increasing demand for accurate and speedy checking-out methods. Urine antigen checking out (UAT) dominates the marketplace, especially in growing areas, due to its fee efficiency and brief results. However, Polymerase Chain Reaction (PCR) checking out is gaining traction due to its accuracy and sensitivity, mainly in biopharmaceutical programs. Clinical laboratories are the primary supply-up customers, benefitting from the growing interest and adoption of superior checking-out strategies. Additionally, environmental trying-out websites are experiencing rapid expansion because of stringent regulations and the advent of onsite trying-out strategies, which protect water structures from Legionella infection.
The North American region led the medical devices market by benefitting a size of USD 126 million in 2023 due to high diagnosis rates for Legionnaire's disease, world-class healthcare infrastructure, high awareness about the disease, and stringent water testing regulations.
The leading players in the legionella testing market significantly influence its growth trajectory and set industry standards. These key players, including Quidel Corporation (U.S.), Abbott (Alere) (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), BD (U.S.), bioMérieux (France), IDEXX Corporation (U.S.), and Eurofins Scientific (Luxembourg), contribute to a competitive landscape, driving innovation and market advancement.
In December 2021, Pace Analytical Services, an enterprise supplying regulatory trying out and evaluation offerings both in-lab and onsite, obtained Special Pathogens Laboratory, a leading participant in Legionella checking out and detection.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2019-2032
Base Year 2023
Estimated Year 2024
Forecast Period 2024-2032
Historical Period 2019-2022
Growth Rate CAGR of 9.7% from 2024-2032
Unit Value (USD million)
Segmentation
By Type
- Culture Media
- Urine Antigen Testing (UAT)
- Polymerase Chain Reaction (PCR)
- Serology
- Direct Fluorescent Antibody (DFA) Test
By End-User
- Hospitals & Clinics
- Clinical Laboratories
- Others
By Geography
- North America (By Type, End-User, and Country)
U.S.
Canada
- Europe (By Type, End-User, and Country/Sub region)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
- Asia Pacific (By Type, End-User, and Country/Sub region)
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Rest of Asia Pacific
- Latin America (By Type, End-User, and Country/Sub region)
Brazil
Mexico
Rest of Latin America
- Middle East & Africa (By Type, End-User, and Country/Sub region)
South Africa
GCC
Rest of the Middle East & Africa
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Legionella Infection, By Key Countries
- 4.2. Key Industry Developments – Merges, Acquisitions and Partnerships
- 4.3. Technological Advancements in Legionella Testing Kits
- 4.4. Regulatory Scenario, By Key Countries
- 4.5. Impact of COVID-19 on the Market
- 5. Global Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast – By Type
- 5.1.1. Culture Media
- 5.1.2. Urine Antigen Testing (UAT)
- 5.1.3. Polymerase Chain Reaction (PCR)
- 5.1.4. Serology
- 5.1.5. Direct Fluorescent Antibody Test (DFA)
- 5.2. Market Analysis, Insights and Forecast – By End User
- 5.2.1. Hospitals & Clinics
- 5.2.2. Clinical Laboratories
- 5.2.3. Others
- 5.3. Market Analysis, Insights and Forecast – By Region
- 5.3.1. North America
- 5.3.2. Europe
- 5.3.3. Asia Pacific
- 5.3.4. Latin America
- 5.3.5. Middle East & Africa
- 6. North America Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast – By Type
- 6.1.1. Culture Media
- 6.1.2. Urine Antigen Testing (UAT)
- 6.1.3. Polymerase Chain Reaction (PCR)
- 6.1.4. Serology
- 6.1.5. Direct Fluorescent Antibody Test (DFA)
- 6.2. Market Analysis, Insights and Forecast – By End User
- 6.2.1. Hospitals & Clinics
- 6.2.2. Clinical Laboratories
- 6.2.3. Others
- 6.3. Market Analysis, Insights and Forecast – By Country
- 6.3.1. U.S.
- 6.3.2. Canada
- 7. Europe Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast – By Type
- 7.1.1. Culture Media
- 7.1.2. Urine Antigen Testing (UAT)
- 7.1.3. Polymerase Chain Reaction (PCR)
- 7.1.4. Serology
- 7.1.5. Direct Fluorescent Antibody Test (DFA)
- 7.2. Market Analysis, Insights and Forecast – By End User
- 7.2.1. Hospitals & Clinics
- 7.2.2. Clinical Laboratories
- 7.2.3. Others
- 7.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 7.3.1. U.K
- 7.3.2. Germany
- 7.3.3. France
- 7.3.4. Italy
- 7.3.5. Spain
- 7.3.6. Russia
- 7.3.7. Rest of Europe
- 8. Asia Pacific Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast – By Type
- 8.1.1. Culture Media
- 8.1.2. Urine Antigen Testing (UAT)
- 8.1.3. Polymerase Chain Reaction (PCR)
- 8.1.4. Serology
- 8.1.5. Direct Fluorescent Antibody Test (DFA)
- 8.2. Market Analysis, Insights and Forecast – By End User
- 8.2.1. Hospitals & Clinics
- 8.2.2. Clinical Laboratories
- 8.2.3. Others
- 8.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 8.3.1. China
- 8.3.2. Japan
- 8.3.3. South Korea
- 8.3.4. India
- 8.3.5. Australia
- 8.3.6. Taiwan
- 8.3.7. Indonesia
- 8.3.8. Rest of Asia Pacific
- 9. Latin America Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast – By Type
- 9.1.1. Culture Media
- 9.1.2. Urine Antigen Testing (UAT)
- 9.1.3. Polymerase Chain Reaction (PCR)
- 9.1.4. Serology
- 9.1.5. Direct Fluorescent Antibody Test (DFA)
- 9.2. Market Analysis, Insights and Forecast – By End User
- 9.2.1. Hospitals & Clinics
- 9.2.2. Clinical Laboratories
- 9.2.3. Others
- 9.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 9.3.1. Brazil
- 9.3.2. Mexico
- 9.3.3. Rest of Latin America
- 10. Middle East & Africa Legionella Testing Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast – By Type
- 10.1.1. Culture Media
- 10.1.2. Urine Antigen Testing (UAT)
- 10.1.3. Polymerase Chain Reaction (PCR)
- 10.1.4. Serology
- 10.1.5. Direct Fluorescent Antibody Test (DFA)
- 10.2. Market Analysis, Insights and Forecast – By End User
- 10.2.1. Hospitals & Clinics
- 10.2.2. Clinical Laboratories
- 10.2.3. Others
- 10.3. Market Analysis, Insights and Forecast – By Country/ Sub-region
- 10.3.1. GCC
- 10.3.2. South Africa
- 10.3.3. Rest of Middle East & Africa
- 11. Competitive Analysis
- 11.1. Global Market Share Analysis (2023)
- 11.2. Company Profiles
- 11.2.1. Quidel Corporation
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Strategies
- 11.2.1.6. financials (Based on Availability)
- 11.2.2. Abbott
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Strategies
- 11.2.2.6. financials (Based on Availability)
- 11.2.3. Merck KGaA
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Strategies
- 11.2.3.6. financials (Based on Availability)
- 11.2.4. Bio-Rad Laboratories, Inc.
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Strategies
- 11.2.4.6. financials (Based on Availability)
- 11.2.5. Thermo Fisher Scientific Inc.
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Strategies
- 11.2.5.6. financials (Based on Availability)
- 11.2.6. BD
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Strategies
- 11.2.6.6. financials (Based on Availability)
- 11.2.7. bioMérieux
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Strategies
- 11.2.7.6. financials (Based on Availability)
- 11.2.8. IDEXX Corporation
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Strategies
- 11.2.8.6. financials (Based on Availability)
- 11.2.9. Eurofins Scientific
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Strategies
- 11.2.9.6. financials (Based on Availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook